Masivukeni: Development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa

AIDS and Behavior

Volumn 17, Issue 6, 2013, Pages 1979-1991

  Remien, Robert H ^a   Mellins, Claude A ^a   Robbins, Reuben N ^a   Kelsey, Ryan ^b   Rowe, Jessica ^b   Warne, Patricia ^a   Chowdhury, Jenifar ^a   Lalkhen, Nuruneesa ^c   Hoppe, Lara ^c   Abrams, Elaine J ^d   El Bassel, Nabila ^b   Witte, Susan ^b   Stein, Dan J ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Department of Medicine   (United States)

Author keywords

ART adherence; HIV; Intervention; Multimedia; Task shifting

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; COUNSELING; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION COMPLIANCE; METHODOLOGY; MULTIMEDIA; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; SELF DISCLOSURE; SOCIAL SUPPORT; SOUTH AFRICA;

ADULT; ANTI-HIV AGENTS; COUNSELING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MULTIMEDIA; PATIENT EDUCATION AS TOPIC; PROGRAM EVALUATION; SELF DISCLOSURE; SOCIAL SUPPORT; SOUTH AFRICA;

EID: 84879011048     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0438-8     Document Type: Article

References (55)

1. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051-8.
2. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115-21.
3. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis. 2001;33(5):700-5.
4. Harrigan PR, Hertogs K, Verbiest W, et al. Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting. AIDS. 1999;13(14):1863-71.
5. Hertogs K, Bloor S, Kemp SD, et al. Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples. AIDS. 2000;14(9):1203-10.
6. Kozal M. Review: cross-resistance patterns among HIV protease inhibitors. AIDS Patient Care STDs. 2004;18(4):199-208.
7. Ives KJ, Jacobsen H, Galpin SA, et al. Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir. J Antimicrob Chemother. 1997;39(6):771-9.
8. Mayers DL. Drug-resistant HIV-1. JAMA. 1998;279(24):2000-2.
9. Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO. Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med. 2001;7(9):1016-20.
10. Blower SM, Aschenbach AN, Kahn JO. Predicting the transmission of drug-resistant HIV: comparing theory with data. Lancet Infect Dis. 2003;3(1):10-1.
11. Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288(2):181-8.
12. Nachega JB, Leisegang R, Bishai D, et al. Association of antiretroviral therapy adherence and health care costs. Ann Intern Med. 2010;152(1):18-25.
13. Sandelowski M, Voils CI, Chang Y, Lee EJ. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care. 2009;21(8):953-66.
14. Simoni J, Amico K, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44-51.
15. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23-35.
16. UNAIDS. UNAIDS report on the global AIDS epidemic. 2010. http://www.unaids.org/globalreport/global-report.htm. Accessed 21 April 2011.
17. National Department of Health. Clinical guidelines for the management of HIV and AIDS in adults and adolescents. Department of Health, Republic of South Africa; 2010.
18. World Health Organization. World health statistics 2010. Geneva: WHO Press; 2010.
19. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America. JAMA. 2006;296(6):679-90.
20. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005;19(12):1243-9.
21. Unge C, Södergård B, Ekström A, et al. Comparing clinic retention between residents and nonresidents of Kibera, Kenya. J Acquir Immune Defic Syndr. 2010;53(3):283-4. doi: 10.1097/QAI.0b013e3181b48c84.
22. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93-108.
23. Ewart CK. Social action theory for a public health psychology. Am Psychol. 1991;46(9):931-46.
24. Traube DE, Holloway IW, Smith L. Theory development for HIV behavioral health: empirical validation of behavior health models specific to HIV risk. AIDS Care. 2011;23:1-8.
25. Uchino B. Social support and health: a review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006;29(4):377-87.
26. Lesserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61(3):397-406.
27. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207-18.
28. Ironson G, Hayward HS. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med. 2008;70(5):546-54.
29. Bedelu M, Ford N, Hilderbrand K, Reuter H. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007;I96(Supplement 3):S464-8.
30. Callaghan M, Ford N, Schneider H. A systematic review of task shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8(1):8.
31. Samb B, Celletti F, Holloway J, Van Damme W, De Cock K, Dybul M. Rapid expansion of the health workforce in response to the HIV epidemic. N Engl J Med. 2007;357(24):2510-4.
32. Walsh A, Ndubani P, Simbaya J, Dicker P, Brugha R. Task sharing in Zambia: HIV service scale-up compounds the human resource crisis. BMC Health Serv Res. 2010;10(1):272.
33. Lehmann U, Van Damme W, Barten F, Sanders D. Task shifting: the answer to the human resources crisis in Africa? Hum Resour Health. 2009;7(1):49.
34. Zachariah R, Teck R, Buhendwa L, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg. 2007;101(1):79-84.
35. Nachega JB, Knowlton AR, Deluca A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study. J Acquir Immune Defic Syndr. 2006;43:S127-33. doi: 10.1097/01.qai.0000248349.25630.3d.
36. Bosworth K, Espelage D, DuBay T, Daytner G, Karageorge K. Preliminary evaluation of a multimedia violence prevention program for adolescents. Am J Health Behav. 2000;24:268-80.
37. Moreno R, Mayer RE, Spires HA, Lester JC. The case for social agency in computer-based teaching: do students learn more deeply when they interact with animated pedagogical agents? Cogn Instr. 2001;19:177-213.
38. Bartholomew LK, Shegog R, Parcel GS, et al. Watch, Discover, Think, and Act: a model for patient education program development. Patient Educ Couns. 2000;39(2):253-68.
39. Rubin DH, Leventhal JM, Sadock RT, et al. Educational intervention by computer in childhood asthma: a randomized clinical trial testing the use of a new teaching intervention in childhood asthma. Pediatrics. 1986;77:1-10.
40. Brown SJ, Lieberman DA, Gemeny BA, Fan YC, Wilson DM, Pasta DJ. Educational video game for juvenile diabetes: results of a controlled trial. Med Inform (Lond). 1997;22:77-89.
41. French D. Influence smoking cessation with computer-assisted instruction. AAOHN J. 1986;34:391-4.
42. Tingen MS, Grimling LF, Bennet G, Gibson EM, Renew MM. A pilot study of preadolescents to evaluate a video game-based smoking prevention strategy. J Addict Nurs. 1997;9:118-24.
43. Reis J, Riley W, Baer J. Interactive multimedia preventive alcohol education: An evaluation of effectiveness with college students. J Educ Comput Res. 2000;23:41-65.
44. Schinke SP, Schwinn TM, Nola JD, Cole KC. Reducing the risk of alcohol use among urban youth: three-year effects of a computer-based intervention with and without parent involvement. J Stud Alcohol. 2004;65:443-9.
45. Bellis JM, Grimley DM, Alexander LR. Feasibility of a tailored intervention targeting STD-related behaviors. Am J Health Behav. 2002;26:378-85.
46. Brown-Peterside P, Redding CA, Ren L, Koblin BA. Acceptability of a stage-matched expert system intervention to increase condom use among women at high risk of HIV infection in New York City. AIDS Educ Prev. 2000;12:171-81.
47. Evans AD, Edmundson-Drane EW, Harris KK. Computer-assisted instruction: an effective instructional method for HIV prevention education? J Adolesc Health. 2000;26:244-51.
48. Knebel E. The use and effect of computer-based training. In: Project QA, editor. Operations research issue paper 1, vol. 2. Bethesda: USAID; 2000.
49. Knebel E. A comparison of computer-based and standard training in the integrated management of childhood illness in Uganda. In: Project QA, editor. Operations research results. Bethesda: USAID; 2002.
50. South Africa Ministry for Welfare and Population Development. White paper for social welfare: principles, guidelines, recommendations, proposed policies and programmes for developmental social welfare in South Africa. http://www.polity.org.za/govdocs/white-papers/social971.html. Accessed 21 April 2011.
51. Wong IY, Lawrence NV, Struthers H, McIntyre J, Friedland GH. Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. J Acquir Immune Defic Syndr. 2006;43:S142-8. doi: 10.1097/01.qai. 0000248345.02760.03.
52. Remien RH, Stirratt MJ, Dognin J, Day E, El-Bassel N, Warne P. Moving from theory to research to practice. Implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S69-78.
53. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19(8):807-14.
54. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184-9.
55. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88:791-804.